×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

GS-III :
  • 12 May, 2020

  • 10 Min Read

ICMR's clearance on using convalescent plasma therapy

ICMR's clearance on using convalescent plasma therapy

Context

The U.S. FDA and India’s ICMR have approved the use of plasma from recovered COVID-19 patients only for trial purposes.

With the ethics committee approval in hand on May 8, the ICMR cleared the last hurdle to conduct a multicentric phase-2 trial using convalescent plasma on COVID-19 patients with moderate illness.

Phase 2 trial- to check the efficacy of Plasma therapy

  • Its three feasibility studies in about 20 severely ill patients found the therapy to be safe and able to resolve illness or improve the clinical symptoms.
  • Since safety of convalescent plasma from people who have recovered from COVID-19 illness is not a huge concern, the first stage of the human clinical trial has been skipped; the ICMR will instead study plasma safety and efficacy in a phase-2 trial with 452 patients.
  • The patients with moderate COVID-19 illness will be randomly assigned to receive either convalescent plasma (226 participants) or only standard of care (control group).
  • The primary outcomes of the trial in 21 hospitals that will be studied include prevention of illness from progressing to a severe form, and avoidance of deaths from all causes at 28 days after plasma infusion.
  • And key secondary outcomes will include resolution of symptoms, reduction in hospital stay and respiratory support.
  • Plasma will be collected from donors 28 days after they make a complete recovery from illness or are symptom-free and have more than the required level of antibodies against the novel coronavirus.
  • Molecular and also other routine tests will be done before plasma use.

Convalescent plasma therapy

Convalescent plasma therapy, about a century old, has shown some benefit in treating measles, chickenpox and rabies.

Small studies have shown faster clearance of virus in the case of MERS and SARS if given early in the course of the disease .

Issues in Convalescent plasma therapy

  • No randomised controlled studies have been carried out.
  • No benefit was seen in 2015 on some Ebola patients treated with convalescent plasma in Guinea.
  • Only three small studies involving 21 COVID-19 patients have been carried out but not in trials where the participants were randomised with a control arm.
  • Till date, there is a dearth of randomised controlled trials that clearly demonstrate the efficacy of convalescent plasma therapy for any infectious disease, including COVID-19.

Way Ahead

Even in the absence of any effective treatment or a vaccine, the pandemic provides an opportunity to ascertain the clinical benefits of plasma therapy through randomised controlled trials.

The ICMR’s insistence on an evidence-based approach to plasma therapy is in contrast to the cavalier manner in which it approved the anti-malarial hydroxychloroquine, as a prophylaxis(treatment given or action taken to prevent disease) for coronavirus without carrying out any trial and relying on evidence that was slim and intended only for treatment, and also when the risks were unknown.

If the trial outcomes are overwhelmingly positive, the agency would be ethically obliged to recommend plasma therapy as a standard of care for COVID-19 patients.

Source: TH


Soil Mapping

Soil Mapping In order to use fertilisers more effectively, the Food and Agriculture Organization (FAO) recently launched a project to digitally map soil nutrients in sub-Saharan Africa (SSA) and central America. Additionally, it will arrange and enhance current soil maps. About soil mapping Soil Mapping is the process of delineating na

New START Treaty

New START Treaty Recently, due to western sanctions, Russia halted inspections under the new START treaty. About New START Treaty The New START treaty, signed in 2010 by President Barack Obama and Russian President Dmitry Medvedev, limits each country to no more than 1,550 deployed nuclear warheads and 700 deployed missiles and bombers,

Palestine - Israel Ceasefire

Palestine - Israel Ceasefire Recently, there was a ceasefire between Israel and Palestine following three days of fighting that claimed the lives of hundreds of people in both nations. Tensions between Palestinians and Israeli police erupted at Jerusalem's al-Aqsa Mosque earlier this year as well. Recent conflict Since Israe

India’s Tourism Market

India’s Tourism Market In 2024, India's outbound tourism will exceed USD 42 billion, according to a report recently published under the title "Outbound Travel and Tourism - An Opportunity Untapped.", released by Nangia Andersen LLP in association with FICCI. Traveling "outside" of one's native country for tou

Food Processing Sector

Food Processing Sector The government's recent efforts to help the food processing sector were recently detailed in a written response to the Rajya Sabha Minister of State (Food Processing Industries). Present status of the food sector in India A type of manufacturing called food processing uses science and technology to transform

Toppers

Search By Date

Newsletter Subscription
SMS Alerts